Skip Ribbon Commands
Skip to main content
Menu
Clin Asst Prof Chong Jun Hua

Clin Asst Prof Chong Jun Hua

B. Med., FRACP, Cardiology, PhD in Clinical and Translational Sciences - Duke-NUS Medical School, Board-certified Cardio-Oncologist by the International Cardio-Oncology Society, Level 2 European Association of Cardiovascular Imaging transthoracic echocardiography accreditation, Level 3 European Association of Cardiovascular Imaging cardiovascular magnetic resonance imaging accreditation

Consultant

National Heart Centre Singapore

Specialty: Cardiology

Sub-specialties: Cardiac Imaging, Cardio-Oncology

Clinical Appointments

  • Consultant Department of Cardiology National Heart Centre SingaporeNational Heart Centre Singapore

Profile

Clinical Assistant Professor Chong Jun Hua is a Consultant from the Department of Cardiology at National Heart Centre Singapore and is board-certified in Cardio-Oncology.

She has received Cardiology training at the Royal Prince Alfred Hospital (Sydney), The Alfred Hospital (Melbourne) and Nepean Hospital (Sydney) and has completed a Fellowship in multimodality cardiac imaging (CMR/ECHO/CT) and Cardio-Oncology at Barts Heart Centre, London.

Clin Asst Prof Chong’s subspecialty clinical interests are in multimodality cardiac imaging and Cardio-oncology and is also actively involved in ongoing research trials on the application of multimodality cardiac imaging to improve cardiovascular outcomes and cardioprotective strategies in Cardio-oncology.

She has completed a PhD in Clinical and Translational Sciences at Duke-NUS Medical School in Cardiovascular Medicine and is currently pursuing a MSc in Clinical Trials at the University of Oxford, Nuffield Department of Population Health, organised in collaboration with the European Society of Cardiology.

Education

  • Bachelor of Medicine (Australia)
  • Fellow of the Royal Australasian College of Physicians (FRACP, Cardiology)
  • PhD in Clinical and Translational Sciences - Duke-NUS Medical School
  • Board-certified Cardio-Oncologist by the International Cardio-Oncology Society - First Cardiologist in Asia to achieve this.
  • Level 2 European Association of Cardiovascular Imaging transthoracic echocardiography accreditation
  • Level 3 European Association of Cardiovascular Imaging cardiovascular magnetic resonance imaging accreditation

Professional Appointments and Committee Memberships

  • Consultant, Department of Cardiology, National Heart Centre Singapore, November 2021 – Present
  • Clinical Assistant Professor, Duke-NUS Medical School, July 2022 - Present
  • Clinical Lecturer at NUS Yong Loo Lin School of Medicine
  • Adjunct Teaching Faculty – Lee Kong Chian School of Medicine
  • Clinical Physician Faculty Member – SingHealth Residency
  • Scientific Committee of the Global Cardio-Oncology Registry established at the Cleveland Clinic Florida, USA
  • International Editorial Board for the South Asian Journal of Cancer
  • Editorial Board for Frontiers in Cardiovascular Medicine journal – Cardio-Oncology section.
  • Associate Consultant, Department of Cardiology, National Heart Centre Singapore, 2019 – October 2021
  • Board member of the International Cardio-Oncology Society – Singapore Chapter
  • Member of European Association of Cardiovascular Imaging, 2017 to present
  • Member of the Global Science and Technology Forum, 2014
  • Singapore Medical Council Specialist Accreditation Board Medical Registration, 2019 to present
  • Australian Health Practitioner Regulation Agency General and Specialist Medical Registration, 2010 to present
  • General Medical Council United Kingdom Medical Registration, 2017 to present

Awards

  • New Toyo Cardiovascular Research and Education Fund research funding award 2022
  • American College of Cardiology Clinical Trials Research Program – Winner of Best Grant Proposals competition with research funding award 2021
  • National Medical Research Council Research Training Fellowship: November 2019 to November 2022 
  • National Medical Research Council CCG- SEED Grant: October 2019 to October 2020
  • First Runner-up in Best Cases around the World category at EuroCMR Congress 2019
  • Winner of “Best Research Paper” award at the 2nd Annual Cardiology and Cardiovascular Medicine Conference, Singapore Dec 2014, hosted by the Global Science and Technology Forum

Research Interests

  • Improving acute myocardial infarction outcomes through pharmacological interventions and telemedicine strategies.
  • Cardioprotection in Cardio-Oncology: Disease mechanisms and therapeutic options.
  • The use of multimodality cardiac imaging techniques to improve understanding and treatment of cardiovascular diseases.
  • Automated analysis of cardiac MRI

Publications

  • A.J. Teske, R. Moudgil, T. López-Fernández, A. Barac, S.A. Brown, A. Deswal, T. G.
    Neilan, S. Ganatra, H. Abdel Qadir, V. Menon, A.L. Sverdlov, R.K. Cheng, S. Makhoul,
    A. K. Ghosh, S. Szmit, V. Zaha, D. Addison, L. Zhang, J. Herrmann, JH Chong, V.
    Agarwala, Z. Lakobishvili, P. Guerrero, EH Yang, M Leja, N. Akhter, A. Guha, T.
    Okwuosa, C. Carvalho Silva, P. Collier, J. DeCara, B. Bauer, C.E. Lenneman, D.
    Sadler. The Global Cardio Oncology Registry (G-COR). Registry design, primary objectives and future perspectives of a multi-center global initiative. Accepted for publication in Circulation: Cardiovascular Quality and Outcomes, July 2023. JIF 8.271.
  • Clark J, Ionescu A, Chahal CAA, Bhattacharyya S, Lloyd G, Galanti K, Gallina S, Chong JH, Petersen SE, Ricci F, Khanji MY. Interchangeability in Left Ventricular Ejection Fraction Measured by Echocardiography and cardiovascular Magnetic Resonance: Not a Perfect Match in the Real World. Curr Probl Cardiol. 2023 Mar 30;48(8):101721. JIF 16.5.
  • Ng CT, Tan LL, Sohn IS, Gonzalez Bonilla H, Oka T, Yinchoncharoen T, Chang WT, Chong JH, Cruz Tan MK, Cruz RR, Astuti A, Agarwala V, Chien V, Youn JC, Tong J, Herrmann J. Advancing Cardio-Oncology in Asia. Korean Circ J. 2023 Feb;53(2):69-91. JIF 2.9. 
  • Chong JH, Abdulkareem M, Petersen SE, Khanji MY. Artificial Intelligence and Cardiovascular Magnetic Resonance Imaging in Myocardial Infarction Patients. Curr Probl Cardiol. 2022 Jul 21;47(12):101330. JIF 16.5.
  • Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: The CONDI-2/ERIC-PPCI CMR substudy.
    Rohin Francis*, Jun Chong*, Manish Ramlall, Chiara Bucciarelli-Ducci, Tim Clayton, Matthew Dodd, Thomas Engstrøm, Richard Evans, Vanessa M Ferreira, Marianna Fontana, John P. Greenwood, Rajesh K. Kharbanda, Won Yong Kim, Tushar Kotecha, Jacob T. Lønborg, Anthony Mathur, Ulla Kristine Møller, James Moon, Alexander Perkins, Roby D Rakhit, Derek M Yellon, Hans Erik Bøtker, Heerajnarain Bulluck**, Derek J. Hausenloy** Basic Res Cardiol. 2021 Oct 14;116(1):59. JIF 17.165.
    * Rohin Francis and Jun Chong are joint first authors. ** Derek J Hausenloy and Heerajnarain Bulluck are joint senior authors.
  • Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients. Sia CH, Chan MH, Zheng H, Ko J, Ho AF, Chong J, Foo D, Foo LL, Lim PZ, Liew BW, Chai P, Yeo TC, Tan HC, Chua T, Chan MY, Tan JWC, Bulluck H, Hausenloy DJ. Cardiovasc Diabetol. 2021 Oct 19;20(1):211. JIF 8.949.
  • Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or stroke. Koo CY, Zheng H, Tan LL, Foo LL, Seet R, Chong JH, Hausenloy DJ, Chng WJ, Richards AM, Lee CH, Chan MY. Sci Rep. 2021 Oct 27;11(1):21167. JIF 4.996.
  • COVID-19 and the Digitalisation of Cardiovascular Training and Education - A Review of Guiding Themes for Equitable and Effective Post-graduate Telelearning. Chong JH, Chahal CAA, Gupta A, Ricci F, Westwood M, Pugliese F, Petersen SE, Khanji MY. Front Cardiovasc Med. 2021 Jul 2;8:666119. doi: 10.3389/fcvm.2021.666119. PMID: 34277728; PMCID: PMC8283504. JIF 6.050
  • Cardiology training using technology. Chong JH, Ricci F, Petersen SE, Khanji MY. Eur Heart J. 2020 Dec 28:ehaa1030. doi: 10.1093/eurheartj/ehaa1030. Epub ahead of print. PMID: 33370432. JIF 22.673
  • The transformation of cardiology training by the COVID-19 pandemic : enhancing current and future standards to deliver optimal patient care. Jun Hua Chong, Anwar Chahal, Fabrizio Ricci, Kyle W Klarich, Victor Ferrari, Jagat Narula and Mohammed Y Khanji. Can J Cardiol. 2021 Mar;37(3):519-522. doi: 10.1016/j.cjca.2021.01.009. Epub 2021 Jan 18. PMID: 33476752; PMCID: PMC7951563. JIF 5.223
  • A Middle-Aged Woman With Recurrent Chest Pain With Troponin Elevation and Unobstructed Coronary Arteries. Jun H Chong, Andreas Baumbach, Mohammed Y Khanji. JAMA Cardiology – Clinical Challenges. JAMA Cardiol. 2021 May 1;6(5):600-601. doi: 10.1001/jamacardio.2021.0116. PMID: 33688912. JIF 14.676
  • Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity. Derek J. Hausenloy, Choon Ta Ng, Jun Hua Chong. J Am Coll Cardiol CardioOnc. 2020 Mar, 2 (1) 53-55.
  • Chronic remote ischemic conditioning for cardiovascular protection. Jun Chong, H. Bulluck, AFW. Ho, W.A. Boisvert, DJ Hausenloy. Conditioning Medicine, 2019, 2(4). 164-169.
  • Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm? Jun Chong, AFW. Ho, J. Yap, H. Bulluck, DJ. Hausenloy. Accepted for publication in Conditioning Medicine, Oct 2019 issue.
  • A review of 5-fluorouracil cardiotoxicity: Proposed pathophysiology, presentation, potential interventions. Jun Chong and AK Ghosh. Interventional Cardiology Review, May 2019, Volume 14(2), Page 89-94 
  • Remote ischemic conditioning in ST-segment elevation myocardial infarction: an update. Jun Chong, Heerajnarain Bulluck, En Ping Yap, Andrew F.W. Ho, William A. Boisvert, Derek J. Hausenloy. Conditioning Medicine, August 2018, Volume 1, Issue 5 
  • Remote ischemic conditioning in Emergency Medicine – clinical frontiers and research opportunities. AFW. Ho, J. Chong, MEH. Ong, DJ. Hausenloy. Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches. March 2020. JIF 3.454
  • The Lipid Paradox is present in ST-elevation but not in non-ST-elevation myocardial infarction patients: Insights from the Singapore Myocardial Infarction Registry. Ching-Hui Sia, Huili Zheng, Andrew Fu-Wah Ho, Heerajnarain Bulluck, Jun Chong, David Foo, Ling-Li Foo, Patrick Zhan Yun Lim, Boon Wah Liew, Huay-Cheem Tan, Tiong-Cheng Yeo, Terrance Siang Jin Chua, Mark Yan-Yee Chan & Derek J. Hausenloy. Sci Rep 10, 6799 (2020). JIF 4.379
  • Effect of remote ischemic preConditioning on liver injury in patients undergoing liver resection: the ERIC-LIVER trial. Jin Yao Teo, Andrew F.W. Ho, Heerajnarain Bulluck, Fei Gao, Jun Chong, Ye Xin Koh, Ek Khoon Tan, Julianah B. Abdul Latiff, Siew H. Chua, Brian K.P. Goh, Chung Yip Chan, Alexander Y.F. Chung, Ser Yee Lee, Peng Chung Cheow, London L.P.J. Ooi, Brian R. Davidson, Prema Raj Jevaraj & Derek J. Hausenloy. HPB (Oxford). 2020; S1365-182X (19) 33218-6. JIF 3.401

Research Trials

  • PASSIvation of Vulnerable plaque with AZD5718 in AcuTe coronary syndrome (PASSIVATE)
  • Acute Myocardial Infarction: allied Health-Oriented Patient-centred digitally-Enabled care (AMI-HOPE)
  • Platelet Inhibition to Target Reperfusion Injury (PITRI trial)
  • Platelet STEMI study: To investigate the effects of high blood glucose at time of STEMI admission on platelet activation and coronary microvascular injury.
  • Improving reModelling in Acute myoCardial infarction Using Live and Asynchronous Telemedicine (IMMACULATE trial)
  • Post-Acute Myocardial Infarction Left ventricular remodeling biomarker Analysis (PAMILA trial)
  • Metabolic Imaging to Detect Anthracycline Cardiomyopathy (MIDAC) study
  • Optimizing cardiac care in cancer patients study
  • Optimising the protocol for remote ischaemic conditioning (RIC): the RIC Protocol study
  • Electroacupuncture for heart protection: clinical application in patients undergoing cardiac bypass surgery
  • Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial